Fludarabine in the Management of Malignant Lymphomas
- 1 January 1994
- journal article
- review article
- Published by Springer Nature in Drugs
- Vol. 47 (6) , 50-56
- https://doi.org/10.2165/00003495-199400476-00008
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group.1994
- Low-grade lymphoma 1993: State of the artAnnals of Oncology, 1994
- Immunosuppressive effects and clinical response of fludarabine in refractory chronic lymphocytic leukemiaAnnals of Oncology, 1993
- Severe immunodeficiency in patients treated with fludarabine monophosphateEuropean Journal of Haematology, 1993
- Treatment of Non-Hodgkin's LymphomaNew England Journal of Medicine, 1993
- Phase II trial of fludarabine phosphate in lymphoma: an effective new agent in low-grade lymphoma.Journal of Clinical Oncology, 1992
- Activity of fludarabine in previously treated non-Hodgkin's low-grade lymphoma: results of an Eastern Cooperative Oncology Group study.Journal of Clinical Oncology, 1992
- Treatment of advanced chronic lymphocytic leukemia by fludarabineAnnals of Hematology, 1991
- Fludarabine phosphate therapy in other lymphoid malignancies.1990
- UPDATED KIEL CLASSIFICATION FOR LYMPHOMASThe Lancet, 1988